Skip to main navigation

Top bar

Biogen.com Information Request Sign up for Alerts Search

Investor Relations

Overview

News

Events Presentations

SEC Filings Annual Reports

Stock Quote & Chart Analyst Coverage Investor FAQs

Governance Documents Committee Composition & Charters Leadership Code of Business Conduct Contact the Board

News

News

News Category

Year

August 24, 2017

IMRALDI®, Biogen’s Adalimumab Biosimilar Referencing Humira®, is Approved in the European Union

July 31, 2017

Biogen Appoints Anabella Villalobos Senior Vice President, Biotherapeutic & Medicinal Sciences

July 25, 2017

Biogen Reports Record Quarterly Revenues of $3.1 Billion, Raises Full Year Revenue Guidance

July 24, 2017

Alisha A. Alaimo Appointed SVP of Biogen’s US Therapeutic Operations

July 14, 2017

Biogen to Present Data at Alzheimer's Association International Conference® 2017 (AAIC®)

July 10, 2017

Biogen Appoints Amy Chevalier Efantis Vice President of Government Affairs

June 29, 2017

New Data Reaffirm Clinically Meaningful Benefit of SPINRAZA® (nusinersen) in Individuals with Spinal Muscular Atrophy Across Disease Severity

June 28, 2017

Biogen Appoints Catherine Steele Senior Vice President of Corporate Affairs

June 23, 2017

Biogen’s IMRALDI®, an Adalimumab Biosimilar Candidate Referencing Humira®, Granted Positive Opinion by Committee for Medicinal Products for Human Use

June 20, 2017

Biogen to Report Second Quarter 2017 Financial Results and Strategic Update on July 25, 2017

Pagination

First page
Previous page
…
Page 6
Page 7
Page 8
Page 9
Current page 10
Page 11
Page 12
Page 13
Page 14
…
Next page
Last page

Displaying 91 - 100 of 653

Footer

Investors
Careers
Our Stories
Contact Us

Follow us

Bottom

Privacy Policy
Terms & Conditions
Forward-Looking Statements
Community Guidelines

Investor Relations

Overview

News

Events & Presentations

Events
Presentations

Financials

SEC Filings
Annual Reports

Stock Information

Stock Quote & Chart
Analyst Coverage
Investor FAQs

Corporate Governance

Governance Documents
Committee Composition & Charters
Leadership
Code of Business Conduct
Contact the Board

Top bar

Biogen.com

Information Request

Sign up for Alerts

Search

Follow us